What Is Enniatin? Definition and What Research Reports

Definition

Enniatin is the collective name for a family of naturally occurring cyclic hexadepsipeptides — closed-ring molecules assembled from three N-methylated amino acid units alternating with three hydroxy-acid (usually 2-hydroxyisovaleric acid) units — that are produced as secondary metabolites by filamentous fungi, principally species of the genus Fusarium. Individual members are distinguished by letters and numbers according to which amino acid residues occupy the ring: enniatin A, enniatin A1, enniatin B, enniatin B1 and several minor analogues. Because Fusarium species commonly infect wheat, barley, oats and maize, enniatins are studied largely as mycotoxins — fungal contaminants of grain and grain-derived foods — rather than as designed drugs. A 2017 review summarised enniatin B as a widely distributed Fusarium metabolite of toxicological interest (PMID 29201864), and a 2023 review described enniatin B1 as an emerging mycotoxin with unresolved regulatory and exposure questions (PMID 37368684). This page is for educational purposes only and is not medical advice; consult a licensed physician for any health question.

Molecular Class and Origin

Depsipeptide, not a conventional peptide

A depsipeptide contains both amide (peptide) bonds and ester bonds. In enniatins, the amide bonds link the N-methylated amino acids while ester bonds join the hydroxy-acid residues, producing an 18-membered macrocycle. The N-methylation and the ester linkages make the molecule highly lipophilic and resistant to ordinary proteolysis, which is why enniatins survive food processing and cross biological membranes readily. Functionally they behave as ionophores: the ring can complex monovalent cations and shuttle them across lipid bilayers, a property that underlies much of the biological activity described in the literature.

Fungal biosynthesis

Enniatins are made non-ribosomally by enniatin synthetase, a multi-domain enzyme, so they are not gene-encoded in the way ribosomal peptides are. The same broad structural family includes beauvericin, a closely related cyclodepsipeptide, and the bassianolides; analytical methods have been developed to separate and quantify enniatins and bassianolides together by liquid chromatography–tandem mass spectrometry (PMID 28619584).

How the Term Is Used in Peptide Research

In the peptide-science literature, "enniatin" appears in three distinct contexts:

• Food and feed toxicology. Enniatin B and B1 are treated as emerging mycotoxins and are surveyed in cereals, with reviews compiling occurrence and hazard data (PMID 29201864, PMID 37368684).
• Structural chemistry. Enniatins are cited as reference examples of cyclodepsipeptides and ionophores when researchers discuss macrocyclisation, N-methylation and membrane permeability in peptide design.
• Mechanistic and preclinical pharmacology. Because the scaffold is cytotoxic to cultured cells, individual enniatins are used as probe molecules in cell-death, mitochondrial and chaperone studies; one 2023 report described enniatin A as an inhibitor of the chaperone Hsp90 with immune-mediated antitumour activity in triple-negative breast cancer models (PMID 38025772).

Enniatin is not an approved drug, is not a therapeutic peptide product, and appears in regulatory documents as a contaminant rather than as an ingredient.

What the Published Literature Reports

Cell-based studies

A 2016 in vitro study characterised enniatin B as cytotoxic and reported accompanying changes in gene expression profile in the cell model used (PMID 27163883). A 2018 assessment examined enniatin A and reported both cytotoxic and genotoxic endpoints in vitro (PMID 29889654). Work published in 2023 compared enniatin B with beauvericin and reported effects on lysosomal cathepsin B secretion together with induction of apoptosis (PMID 36768354). Taken together, researchers have consistently described the enniatin scaffold as active against cultured cells at the concentrations tested in those experiments.

Developmental and reproductive models

A 2019 study reported that enniatin B1 exerted embryotoxic effects on mouse blastocysts and induced oxidative stress and immunotoxicity during embryo development (PMID 30259633). A 2021 study in porcine early embryos reported that melatonin protected against defects induced by enniatin B1 in that model (PMID 33589578). These are animal and in vitro embryo systems, not human data.

Metabolism and toxicokinetics

A 2017 comparative study examined the biotransformation of enniatin B1 in pigs using both in vitro and in vivo approaches (PMID 28472676). A 2022 study characterised cytochrome P450 isoform contribution, plasma protein binding and toxicokinetics of enniatin A in rats and used those data to predict in vivo clearance in humans (PMID 35398446). The study designs were toxicokinetic rather than therapeutic — they asked how the molecule is handled by the body, not whether it benefits anyone.

Environmental work

A 2024 study reported that beauvericin and enniatin B altered aquatic ecosystem endpoints, with effects observed on green algae (PMID 38503354). This line of work treats enniatins as environmental contaminants that reach water systems from agricultural sources.

Named Enniatins at a Glance

Toxicity Signals in Research Models: What Studies Report

The published record on enniatins is dominated by toxicology rather than therapeutics. Researchers have reported cytotoxicity in cultured cells for enniatin A and enniatin B (PMID 29889654, PMID 27163883), apoptosis induction alongside altered lysosomal cathepsin B secretion (PMID 36768354), and oxidative stress plus immunotoxicity during embryo development in a mouse model exposed to enniatin B1 (PMID 30259633). Review articles have framed enniatin B and enniatin B1 as emerging mycotoxins whose human exposure and risk characterisation remain open questions (PMID 29201864, PMID 37368684). No human clinical trial data establishing safety or benefit appears in the verified sources summarised here.

Limits of the Evidence

1. Model systems dominate. Most findings come from cell culture, embryo models, pigs, rats or algae; extrapolation to human outcomes was not established in the cited work.
2. Exposure context differs from intentional administration. The studies were designed around dietary and environmental contamination, and the 2017 pig biotransformation work and 2022 rat toxicokinetic work asked how the compound is metabolised and cleared (PMID 28472676, PMID 35398446).
3. Analytical variability. Occurrence estimates depend on detection methods, and dedicated chromatographic methods have been developed for enniatins and related cyclodepsipeptides (PMID 28619584).
4. Anticancer reports are preclinical. The Hsp90-related antitumour observation for enniatin A came from laboratory models of triple-negative breast cancer (PMID 38025772), not from clinical use.

References

• Enniatin B1: Emerging Mycotoxin and Emerging Issues (Toxins, 2023)
• A Review of the Mycotoxin Enniatin B (Frontiers in Public Health, 2017)
• Fusarium mycotoxin enniatin B: Cytotoxic effects and changes in gene expression profile (Toxicology in Vitro, 2016)
• Assessment of cytotoxic and genotoxic effects of enniatin-A in vitro (Food Additives & Contaminants Part A, 2018)
• Impact of Enniatin B and Beauvericin on Lysosomal Cathepsin B Secretion and Apoptosis Induction (International Journal of Molecular Sciences, 2023)
• Enniatin B1 exerts embryotoxic effects on mouse blastocysts and induces oxidative stress and immunotoxicity during embryo development (Environmental Toxicology, 2019)
• Melatonin protects against defects induced by Enniatin B1 during porcine early embryo development (Aging, 2021)
• Biotransformation of the mycotoxin enniatin B1 in pigs: A comparative in vitro and in vivo approach (Food and Chemical Toxicology, 2017)
• Cytochrome P450 isoforms contribution, plasma protein binding, toxicokinetics of enniatin A in rats and in vivo clearance prediction in humans (Food and Chemical Toxicology, 2022)
• Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancer (iScience, 2023)
• Beauvericin and enniatin B mycotoxins alter aquatic ecosystems: Effects on green algae (Environmental Toxicology and Pharmacology, 2024)
• Application of C8 liquid chromatography-tandem mass spectrometry for the analysis of enniatins and bassianolides (Journal of Chromatography A, 2017)